[HTML] frontiersin.org

[HTML][HTML] Phosphoinositide 3-kinase signaling pathway in pancreatic ductal adenocarcinoma progression, pathogenesis, and therapeutics

D Murthy, KS Attri, PK Singh - Frontiers in physiology, 2018 - frontiersin.org
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterized
by its sudden manifestation, rapid progression, poor prognosis, and limited therapeutic …
被引用次数：83 相关文章
[HTML] nih.gov

[HTML][HTML] Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics

D Murthy, KS Attri, PK Singh - Frontiers in Physiology, 2018 - ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterized
by its sudden manifestation, rapid progression, poor prognosis, and limited therapeutic …

Phosphoinositide 3-kinase signaling pathway in pancreatic ductal adenocarcinoma progression, pathogenesis, and therapeutics

D Murthy, KS Attri, PK Singh - Frontiers in Physiology, 2018 - experts.nebraska.edu
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterized
by its sudden manifestation, rapid progression, poor prognosis, and limited therapeutic …
[PDF] core.ac.uk

[PDF][PDF] Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics

D Murthy, KS Attri, PK Singh - core.ac.uk
Of PDAC tunnOrS harbor Criver mutationS in K-Pas that aCtivate varjOUS COwnStreann
effector-signaling pathways, including the phosphoinositide-3-kinase (P3K) pathway The …

Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics

D Murthy, KS Attri, PK Singh - Frontiers in physiology, 2018 - pubmed.ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterized
by its sudden manifestation, rapid progression, poor prognosis, and limited therapeutic …
[HTML] frontiersin.org

[HTML][HTML] Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics

D Murthy, KS Attri, PK Singh - Frontiers in Physiology, 2018 - frontiersin.org
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterized
by its sudden manifestation, rapid progression, poor prognosis, and limited therapeutic …

Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics.

D Murthy, KS Attri, PK Singh - Frontiers in Physiology, 2018 - europepmc.org
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterized
by its sudden manifestation, rapid progression, poor prognosis, and limited therapeutic …
[PDF] academia.edu

[PDF][PDF] Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics

D Murthy, KS Attri, PK Singh - Front. Physiol. 9: 335. doi: 10.3389 …, 2018 - academia.edu
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterized
by its sudden manifestation, rapid progression, poor prognosis, and limited therapeutic …

Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics

D Murthy, KS Attri, PK Singh - Frontiers in Physiology, 2018 - digitalcommons.unmc.edu
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterized
by its sudden manifestation, rapid progression, poor prognosis, and limited therapeutic …

Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics.

D Murthy, KS Attri, PK Singh - Frontiers in Physiology, 2018 - europepmc.org
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterized
by its sudden manifestation, rapid progression, poor prognosis, and limited therapeutic …